Skip to main content
. 2022 Jul 14;37(1):1995–2003. doi: 10.1080/14756366.2022.2098954

Figure 7.

Figure 7.

Compound C6 regulated PI3K/AKT pathway against TE-1 (A) and EC109 (B) cells.